See more : DD3 Acquisition Corp. II (DDMXU) Income Statement Analysis – Financial Results
Complete financial analysis of Aurora Spine Corporation (ASAPF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aurora Spine Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Toyo Asano Foundation Co., Ltd. (5271.T) Income Statement Analysis – Financial Results
- News Corporation (NWS) Income Statement Analysis – Financial Results
- Braskem S.A. (BRKM3.SA) Income Statement Analysis – Financial Results
- SGS SA (0QMI.L) Income Statement Analysis – Financial Results
- Coca-Cola Bottlers Japan Holdings Inc. (CCOJY) Income Statement Analysis – Financial Results
Aurora Spine Corporation (ASAPF)
About Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTRA, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases; and Ti-Coated polyether ether ketone interbody cages, which provide spacing and stability between the vertebrae while bone grows to complete the fusion process. It also provides sterile-packed titanium plasma spray coated spinal infusion implants for bone growth, as well as interbody products, such as EOS, VOX, Echo, Echo SD, and EchoXL for the lumbar section of the spine, and discovery for cervical procedures. In addition, the company provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior fusion device for the sacroiliac joint. Further, it offers DEXA-C, a cervical interbody system, which is a porous 3D-printed intervertebral body fusion device that incorporates low-, mid-, or high-density lattice pattern options to support the matching of patients' bone quality. Aurora Spine Corporation was incorporated in 2013 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.52M | 14.88M | 10.54M | 8.65M | 11.15M | 8.68M | 5.99M | 6.76M | 4.90M | 2.59M | 206.99K |
| Cost of Revenue | 6.31M | 7.07M | 5.71M | 5.18M | 7.61M | 4.09M | 3.43M | 3.37M | 2.21M | 1.14M | 82.80K |
| Gross Profit | 8.21M | 7.81M | 4.83M | 3.47M | 3.55M | 4.59M | 2.56M | 3.38M | 2.69M | 1.45M | 124.19K |
| Gross Profit Ratio | 56.55% | 52.49% | 45.84% | 40.12% | 31.81% | 52.90% | 42.73% | 50.08% | 54.91% | 56.04% | 60.00% |
| Research & Development | 1.11M | 1.16M | 941.30K | 286.25K | 207.55K | 36.30K | 21.06K | 40.41K | 78.12K | 280.69K | 158.19K |
| General & Administrative | 6.82M | 6.08M | 4.99M | 3.65M | 3.89M | 3.64M | 3.70M | 4.11M | 4.71M | 7.30M | 1.14M |
| Selling & Marketing | 722.29K | 1.05M | 799.93K | 106.01K | 138.92K | 47.14K | 31.86K | 91.43K | 287.68K | 1.00M | 140.28K |
| SG&A | 7.54M | 7.12M | 5.79M | 3.76M | 4.03M | 3.68M | 3.74M | 4.20M | 5.00M | 8.30M | 1.28M |
| Other Expenses | 0.00 | 868.59K | 648.69K | 589.54K | 386.65K | 780.56K | 984.11K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 8.66M | 9.15M | 7.38M | 4.63M | 4.63M | 4.50M | 4.74M | 5.00M | 5.81M | 8.96M | 1.45M |
| Cost & Expenses | 14.97M | 16.22M | 13.10M | 9.81M | 12.23M | 8.59M | 8.17M | 8.37M | 8.02M | 10.10M | 1.45M |
| Interest Income | 0.00 | 0.00 | 0.00 | 4.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 185.17K | 163.60K | 157.70K | 92.35K | 174.01K | 147.59K | 144.65K | 60.93K | 26.93K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.05M | 834.17K | 642.98K | 620.68K | 395.64K | 740.76K | 855.88K | 752.84K | 750.81K | 385.82K | 3.80K |
| EBITDA | -446.20K | -450.68K | -1.54M | -686.23K | -709.74K | 816.09K | -1.35M | -869.19K | -2.00M | -7.15M | -3.40M |
| EBITDA Ratio | -3.07% | -2.74% | -18.03% | -6.64% | -6.21% | 10.04% | -22.62% | -12.67% | -52.56% | -274.90% | -696.43% |
| Operating Income | -446.20K | -1.34M | -2.55M | -1.16M | -1.08M | 91.44K | -2.18M | -1.68M | -3.12M | -7.51M | -1.45M |
| Operating Income Ratio | -3.07% | -9.03% | -24.19% | -13.46% | -9.68% | 1.05% | -36.42% | -24.85% | -63.70% | -289.79% | -698.27% |
| Total Other Income/Expenses | -1.23M | -158.06K | 191.04K | 931.31K | -174.79K | -159.64K | -59.30K | 0.00 | 205.32K | 0.00 | 0.00 |
| Income Before Tax | -1.68M | -1.50M | -2.36M | -232.09K | -1.25M | -68.20K | -2.24M | -1.68M | -2.92M | -7.51M | -1.45M |
| Income Before Tax Ratio | -11.57% | -10.09% | -22.37% | -2.68% | -11.25% | -0.79% | -37.41% | -24.85% | -59.51% | -289.79% | -698.27% |
| Income Tax Expense | 0.00 | 62.29K | 159.10K | 87.71K | 174.01K | 12.05K | -85.35K | 60.93K | -205.32K | 0.00 | 0.00 |
| Net Income | -1.68M | -1.56M | -2.52M | -319.80K | -1.43M | -80.25K | -2.16M | -1.68M | -2.92M | -7.51M | -1.45M |
| Net Income Ratio | -11.57% | -10.51% | -23.88% | -3.70% | -12.81% | -0.92% | -35.98% | -24.85% | -59.51% | -289.79% | -698.27% |
| EPS | -0.02 | -0.02 | -0.04 | -0.01 | -0.03 | 0.00 | -0.06 | -0.05 | -0.11 | -0.35 | -0.22 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.01 | -0.03 | 0.00 | -0.06 | -0.05 | -0.11 | -0.35 | -0.22 |
| Weighted Avg Shares Out | 70.67M | 66.80M | 58.71M | 54.63M | 46.46M | 42.15M | 35.18M | 32.22M | 25.95M | 21.62M | 6.58M |
| Weighted Avg Shares Out (Dil) | 70.67M | 66.80M | 58.71M | 54.63M | 46.46M | 42.15M | 35.18M | 32.22M | 25.95M | 21.62M | 6.58M |
Aurora Spine Corporation (ASAPF) Q3 2024 Earnings Call Transcript
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2024 Financial Results
Aurora Spine Corporation Announces Third Quarter 2024 Financial Results
Aurora Spine Corporation Announces Release of its Hydra Osteo Onyx Lumbar System
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
Aurora Spine Corporation Announces Second Quarter 2024 Financial Results
Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
Aurora Spine Corporation Announces First Quarter 2024 Financial Results
Source: https://incomestatements.info
Category: Stock Reports